Page last updated: 2024-11-02

pentobarbital and Menopause

pentobarbital has been researched along with Menopause in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CRISP, GO1

Other Studies

1 other study available for pentobarbital and Menopause

ArticleYear
A NEW LOOK AT PENTOBARBITAL.
    Western medicine; the medical journal of the west, 1964, Volume: 5

    Topics: Anxiety; Anxiety Disorders; Dementia; Female; Heart Diseases; Humans; Hypertension; Menopause; Neuro

1964